Trim 25-40% of TXN into strength; fair-value pricing and bearish signals warrant meaningful reduction while preserving optionality into Q3 2026 catalyst
TXN remains Underweight (not Sell) because structural thesis is intact: 200 SMA rising at $234.50 (13.7% below current), Dividend Aristocrat status, fortress balance sheet (1.1x net leverage, 4.86x current ratio), 35% ROE, FCF inflecting from $555M to $2.19B YoY, gross margin re-expanding to 61.4%. The 25-40% trim (not the neutral's undersized 10-15%) is warranted by three concurrent signals: Forward P/E math collapsing any discount-to-fair-value framing, five bearish technical signals confirming lower-high sequence ($330→$311→$299→$296→$290), and 28% receivables spike flagging channel-stuffing risk at cyclical inflection. Execution favors scaling out into $273 (20 SMA/Bollinger middle) and $285 (50 SMA) resistance rather than current weakness. Covered calls at $285 rejected — capping upside at trend-reversal level surrenders move to call buyers; retain full optionality into Jackson Hole binary.
| Position | Action |
|---|---|
| Full conviction trim | 40% reduction |
| Moderate conviction trim | 25-40% reduction |
| Residual position stop | $255 daily close (Aug 24 swing low) |
TXN is a high-quality compounder in a mid-cycle pullback, with Q2 2026 confirming an accelerating earnings recovery, DCF-implied 22% upside, intact long-term uptrend, and structural AI/electrification tailwinds alongside a CapEx normalization-driven FCF inflection.
| Indicator | Value | Signal |
|---|---|---|
| Close Price | $266.54 | neutral |
| 10 EMA | $266.95 | neutral |
| 50 SMA | $285.85 | bearish |
| 200 SMA | $234.50 | bullish |
| RSI (14-day) | 43.43 | neutral |
| RSI (14-day) Low | 36.38 | bearish |
| MACD | -6.21 | bearish |
| MACD Signal | -5.48 | bearish |
| MACD Histogram | -0.74 | neutral |
| Bollinger Upper Band | $289.82 | bearish |
| Bollinger Middle (20 SMA) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Volume-confirmed 50 SMA reclaim above $285.85
Then: Re-evaluate overweight stance
Long-term uptrend remains intact despite tactical 50 SMA resistance
↩ rebuts: “Bear technical case citing 50 SMA breakdown and negative MACD”
EV: +22% (DCF-implied upside to $324.45 from $266.54) · concedes: Bear case is intellectually defensible; 50 SMA is a valid tactical resistance level; Near-term volatility is elevated; Waiting for 'perfect confirmation' is a rational approach, just potentially costly
TXN's Q2 2026 was a cyclical peak disguised as secular acceleration, with the stock already at fair value on forward earnings while facing a broken technical downtrend, margin re-compression risk, and binary macro risk that collectively create asymmetric downside to $176-238.
EV: -$176 to $238 (base case $238, -11%; bear case $176, -34%) · concedes: The bull is correct that TTM P/E of 40x is distorted by cyclical trough; Capital return (20+ years dividend growth) provides a floor at current levels; 200 SMA at $234.50 is technically intact as a long-term trend anchor
→ vs conservative: Waiting for 50 SMA reclaim at $285.85 to add is illogical when you should trim at $266 to avoid giving back another 7%; sitting through a known lower-high sequence is hope, not risk management
→ vs conservative: Receivables spike of 28% barely acknowledged; deteriorating collection velocity is a textbook channel-stuffing warning sign at the cyclical peak
→ vs conservative: Advising to stay patient through elevated implied volatility into a binary Warsh speech is gambling, not risk management
→ vs neutral: Simply Wall St. DCF of $324.45 requires three independent assumptions (multiple expansion, earnings delivery, macro stability) all hitting simultaneously—zero margin of safety
→ vs neutral: 23% Y/Y revenue growth quality is suspect given the receivables dynamics; smart money sells into strength when underlying receivables flash yellow
→ vs neutral: Forward P/E of 25x with PEG of 1.15 means the recovery is already priced in; high-quality cyclical compounder does not command expanding multiple at cyclical peak
→ vs neutral: Bear case math on $266 fair value at 25.04x earnings is dispositive against the bull thesis
| $273.09 |
| neutral |
| Bollinger Lower Band | $256.35 | bullish |
| ATR (14-day) | $9.43 | neutral |
| Volume (Aug 27) | 5.6M | neutral |
| Volume (Jun 26 breakdown) | 29.8M | bearish |
Support: 234.5 · 255.18 · 256.35 · 261.23 | Resistance: 273.09 · 285.85 · 289.82
TXN is at a critical inflection point with long-term uptrend intact (above rising 200 SMA at $234.50) but intermediate-term downtrend confirmed (below falling 50 SMA at $285.85). The Aug 24 tag of the Bollinger Lower Band ($256.35) triggered a tactical bounce, with RSI recovering from oversold (36.38) and MACD histogram improving to -0.74, but no confirmed reversal yet. Key reclaim levels are $285.85 (50 SMA) for trend reversal confirmation and $273.09 (Bollinger Middle) as immediate resistance. The rating is HOLD: existing holders should maintain positions while awaiting either a sustained close above $285.85 (would upgrade to BUY) or a close below $255 (would warrant trimming).
Market Cap
$243.4 B
Share Price (50D avg)
~$287.54
52-Week High
$334.03
52-Week Low
$152.73
200-Day Average
$235.95
Beta
1.325
TTM P/E
40.57x
Forward P/E
25.04x
PEG Ratio
1.15
P/B
13.51x
EPS (TTM)
$6.57
Forward EPS
$10.64
Dividend Yield
2.17%
Book Value/Share
$19.72
Gross Margin (TTM)
58.3%
Operating Margin (TTM)
42.6%
Net Profit Margin (TTM)
31.1%
ROE (TTM)
35.2%
ROA (TTM)
13.1%
Q2 2026 Revenue
$5,463M
Q2 2026 Net Income
$1,980M
Q2 2026 Diluted EPS
$2.14
Q2 2026 Gross Margin
61.4%
Q2 2026 Free Cash Flow
$2,189M
Q2 2026 CapEx
$514M
Q2 2026 Cash & ST Investments
$7,001M
Q2 2026 Inventory
$4,605M
Q2 2026 Long-Term Debt
$12,903M
Q2 2026 Current Debt
$1,149M
Q2 2026 Total Debt
$14,052M
Q2 2026 Net Debt
$10,392M
Q2 2026 Debt/Equity
78%
Q2 2026 Current Ratio
4.86x
2025 Revenue
$17,682M
2025 Gross Profit
$10,083M
2025 Operating Income
$6,140M
2025 Net Income
$5,001M
2025 Diluted EPS
$5.45
2025 Gross Margin
57.0%
2025 Operating Margin
34.7%
2025 Operating Cash Flow
$7,153M
2025 CapEx
$4,550M
2025 Free Cash Flow
$2,603M
2025 Dividends Paid
$4,999M
2025 Buybacks
$1,477M
2024 Revenue
$15,641M
2024 Net Income
$4,799M
2024 Diluted EPS
$5.20
2024 Gross Margin
58.1%
2024 Operating Margin
34.9%
2022 Revenue
$20,028M
2022 Net Income
$8,749M
2022 Diluted EPS
$9.41
2022 Gross Margin
68.8%
2022 Operating Margin
50.6%
2025 R&D Spend
$2.08B
2025 SG&A
$1.86B
Annual Dividend Run-Rate
~$5.2B
Quarterly Dividend
$1.30+
Product Portfolio
~80,000 SKUs
Product Lifecycle
10+ years
Bear Case Price Target
~$200/share
Bull Case Price Target
~$330/share
Strengths
Concerns
HOLD
Macro: Fed holds 88% probability of zero rate cuts in 2026 (up +2.2pp WoW); US recession odds at 8% by EOY26 (rising +1pp WoW); mortgage rates sticky near 6.7% pressuring housing/industrial channels; Jackson Hole keynote (Aug 28) is a high-risk event catalyst; post-Nvidia 'rosy view' reinforces AI capex narrative as a cross-asset positive for semiconductor analog exposure.